George Bellow

SOMAí Pharmaceuticals Ltd. is a European pharmaceutical and Irish biotech company that was founded in 2019 by Michael Sassano and George Bellow. The company is based in Dublin, Ireland. SOMAí Pharmaceuticals is a large-scale manufacturer of cannabis products that invests in the extraction, research, development, formulation, and distribution of EU GMP-pharmaceutical market-authorized cannabinoid products. The company is committed to revolutionizing healthcare through cannabis-based treatments and emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system. SOMAí Pharmaceuticals is the largest and most advanced cannabinoid manufacturing facility in markets, producing medicines products and registered APIs. Michael Sassano has been the CEO since 2019.

SOMAí Pharmaceuticals Ltd. is a European pharmaceutical and Irish biotech company that was founded in 2019 by Michael Sassano and George Bellow. The company is based in Dublin, Ireland. SOMAí Pharmaceuticals is a large-scale manufacturer of cannabis products that invests in the extraction, research, development, formulation, and distribution of EU GMP-pharmaceutical market-authorized cannabinoid products. The company is committed to revolutionizing healthcare through cannabis-based treatments and emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system. SOMAí Pharmaceuticals is the largest and most advanced cannabinoid manufacturing facility in markets, producing medicines products and registered APIs. Michael Sassano has been the CEO since 2019.